Recently, an activating mutation of the SRC gene has been implicated in abo
ut one-tenth of advanced colon cancers. The SRC 531 mutation results in tru
ncation of SRC directly C-terminal to the regulatory Tyr 530 and appears to
activate the Tyr 530, To investigate whether mutation of SRC plays an impo
rtant role in the development and progression of gynecological tumors, we p
erformed mutational analysis of the entire coding region of SRC in 70 ovari
an carcinomas, 68 endometrial carcinomas and 3 endometrial stromal sarcomas
by means of polymerase chain reaction-single strand conformation polymorph
ism (PCR-SSCP) followed by nucleotide sequencing and restriction fragment L
ength polymorphism (RFLP) analysis. We found one truncated mutation at codo
n 531 (Gln to Stop) in an endometrial carcinoma. However, we found no mutat
ion of this gene in ovarian carcinoma or endometrial stromal sarcoma. Our r
esults suggest that mutation of SRC may be implicated in a small proportion
of endometrial carcinomas.